Related Experiment Videos
[Shock-treatment in gastro-intestinal-bleeding with 3,5% isocyanate crosslinked polypeptide solution]
Der Anaesthesist
|July 1, 1982
In a prospective study infusions of 3,5% isocyanate crosslinked polypeptide solution 500 ml (Haemaccel 3,5%) were given to patients with gastro-intestinal-bleeding for shock treatment and prophylaxis. The increase in intravascular volume was always satisfactory. We did not see any undesirable side effects (anaphylaxis, anaphylactoid reaction, coagulopathy, oliguria).
In a prospective study infusions of 3,5% isocyanate crosslinked polypeptide solution 500 ml (Haemaccel 3,5%) were given to patients with gastro-intestinal-bleeding for shock treatment and prophylaxis. The increase in intravascular volume was always satisfactory. We did not see any undesirable side effects (anaphylaxis, anaphylactoid reaction, coagulopathy, oliguria).